|
|
|
Insider
Information: |
Henneman John B III |
Relationship: |
Director |
City: |
|
State: |
|
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
8 |
|
Direct
Shares |
263,813 |
|
Indirect Shares
|
0 |
|
|
Direct
Value |
$3,781,284 |
|
|
Indirect Value
|
$0 |
|
|
Total
Shares |
263,813 |
|
|
Total
Value |
$3,781,284 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
1
|
1
|
Stock
price went up :
|
0
|
0
|
Stock
price went down : |
1
|
1
|
|
|
|
Gain/Loss Ratio : |
-1.0
|
-1.0
|
Percentage
Gain/Loss : |
-27.9%
|
-30.9%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Integra Lifesciences Holdings Corp |
IART |
CorpVP, CAO |
2014-08-25 |
34,159 |
2003-07-14 |
0 |
Premium* |
|
Lumos Pharma Inc |
LUMO |
Chief Administrative O... |
2018-10-01 |
55,052 |
2014-10-01 |
0 |
Premium* |
|
Seaspine Holdings Corp |
SPNE |
Director |
2023-01-05 |
0 |
2016-06-07 |
0 |
Premium* |
|
R1 RCM Inc |
ACHI |
Director |
2022-06-21 |
0 |
2016-08-16 |
0 |
Premium* |
|
Aprea Therapeutics, Inc. |
APRE |
Director |
2024-03-13 |
8,139 |
2019-10-07 |
0 |
Premium* |
|
Anika Therapeutics Inc |
ANIK |
Director |
2023-06-14 |
29,936 |
2020-09-03 |
0 |
Premium* |
|
R1 Rcm Inc |
RCM |
Director |
2024-05-23 |
87,765 |
2022-06-21 |
0 |
Premium* |
|
Orthofix International N.V. |
OFIX |
Director |
2023-01-05 |
48,762 |
2023-01-05 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
168 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 3 of 7
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
LUMO |
Lumos Pharma Inc |
EVP, Chief Financial Officer |
|
2015-05-14 |
4 |
B |
$37.30 |
$111,900 |
D/D |
3,000 |
50,489 |
2.74 |
- |
|
ACHI |
R1 RCM Inc |
Director |
|
2016-08-16 |
4 |
B |
$1.77 |
$90,098 |
D/D |
50,000 |
50,000 |
2.39 |
- |
|
APRE |
Aprea Therapeutics, Inc. |
|
|
2019-10-07 |
4 |
B |
$15.00 |
$75,000 |
D/D |
5,000 |
5,000 |
0.01 |
- |
|
ANIK |
Anika Therapeutics Inc |
Director |
|
2021-05-18 |
4 |
B |
$42.86 |
$85,720 |
D/D |
2,000 |
11,310 |
2.39 |
% |
|
APRE |
Aprea Therapeutics, Inc. |
Director |
|
2024-03-13 |
4 |
B |
$7.29 |
$50,009 |
D/D |
6,860 |
8,139 |
2.39 |
- |
|
IART |
Integra Lifesciences Hold... |
EVP, Finance & Admin & CFO |
|
2009-01-02 |
4 |
D |
$35.57 |
$1,616,657 |
D/D |
(45,450) |
86,628 |
0 |
- |
|
IART |
Integra Lifesciences Hold... |
EVP, Finance & Admin & CFO |
|
2009-12-18 |
4 |
D |
$35.45 |
$110,108 |
D/D |
(3,106) |
89,535 |
0 |
- |
|
IART |
Integra Lifesciences Hold... |
EVP, Finance & Admin & CFO |
|
2010-01-04 |
4 |
D |
$36.87 |
$58,550 |
D/D |
(1,588) |
92,313 |
0 |
- |
|
IART |
Integra Lifesciences Hold... |
EVP, Finance & Admin & CFO |
|
2010-03-15 |
4 |
D |
$42.33 |
$108,576 |
D/D |
(2,565) |
89,748 |
0 |
- |
|
IART |
Integra Lifesciences Hold... |
EVP, Finance & Admin & CFO |
|
2010-12-16 |
4 |
D |
$47.84 |
$1,390,565 |
D/D |
(29,067) |
118,067 |
0 |
- |
|
IART |
Integra Lifesciences Hold... |
EVP, Finance & Admin & CFO |
|
2011-01-03 |
4 |
D |
$47.30 |
$59,882 |
D/D |
(1,266) |
120,656 |
0 |
- |
|
IART |
Integra Lifesciences Hold... |
EVP, Finance & Admin & CFO |
|
2012-02-22 |
4 |
D |
$30.86 |
$65,794 |
D/D |
(2,132) |
72,542 |
0 |
- |
|
IART |
Integra Lifesciences Hold... |
CorpVP, Finance & Admin, CFO |
|
2013-12-13 |
4 |
D |
$45.66 |
$185,288 |
D/D |
(4,058) |
68,611 |
0 |
- |
|
IART |
Integra Lifesciences Hold... |
CorpVP, Finance & Admin, CFO |
|
2014-03-25 |
4 |
D |
$45.77 |
$57,670 |
D/D |
(1,260) |
68,458 |
0 |
- |
|
IART |
Integra Lifesciences Hold... |
CorpVP, CAO |
|
2014-05-23 |
4 |
D |
$44.82 |
$640,881 |
D/D |
(14,299) |
54,159 |
0 |
- |
|
LUMO |
Lumos Pharma Inc |
EVP, Chief Financial Officer |
|
2015-10-01 |
4 |
D |
$35.32 |
$148,309 |
D/D |
(4,199) |
46,290 |
0 |
- |
|
LUMO |
Lumos Pharma Inc |
EVP, Chief Financial Officer |
|
2016-10-01 |
4 |
D |
$15.02 |
$41,891 |
D/D |
(2,789) |
60,099 |
0 |
- |
|
LUMO |
Lumos Pharma Inc |
EVP, Chief Financial Officer |
|
2017-01-03 |
4 |
D |
$10.28 |
$1,686 |
D/D |
(164) |
59,935 |
0 |
- |
|
LUMO |
Lumos Pharma Inc |
EVP, Chief Financial Officer |
|
2017-01-04 |
4 |
D |
$11.04 |
$14,606 |
D/D |
(1,323) |
58,612 |
0 |
- |
|
LUMO |
Lumos Pharma Inc |
EVP, Chief Financial Officer |
|
2017-10-01 |
4 |
D |
$10.18 |
$28,392 |
D/D |
(2,789) |
56,544 |
0 |
- |
|
LUMO |
Lumos Pharma Inc |
EVP, Chief Financial Officer |
|
2018-01-02 |
4 |
D |
$8.47 |
$1,389 |
D/D |
(164) |
58,859 |
0 |
- |
|
LUMO |
Lumos Pharma Inc |
EVP, Chief Financial Officer |
|
2018-01-04 |
4 |
D |
$10.06 |
$13,309 |
D/D |
(1,323) |
57,536 |
0 |
- |
|
LUMO |
Lumos Pharma Inc |
Chief Administrative Officer |
|
2018-10-01 |
4 |
D |
$2.28 |
$5,664 |
D/D |
(2,484) |
55,052 |
0 |
- |
|
ACHI |
R1 RCM Inc |
Director |
|
2022-06-21 |
4 |
D |
$0.00 |
$0 |
D/D |
(54,751) |
0 |
0 |
- |
|
SPNE |
Seaspine Holdings Corp |
Director |
|
2023-01-05 |
4 |
D |
$0.00 |
$0 |
D/D |
(82,654) |
0 |
0 |
- |
|
168 Records found
|
|
Page 3 of 7 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|